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Introduction
Suprachoroidal hemorrhage, typically an explosive accu-
mulation of blood within the suprachoroidal space, is
an uncommon but devastating complication of intraoc-
ular surgery. Spontaneous suprachoroidal hemorrhage,
which occurs unrelated to surgery, is much rarer and can
also result in irreversible loss of vision. We present a
patient with age-related macular degeneration (ARMD)
who was under anticoagulation therapy due to sys-
temic disease. Spontaneous suprachoroidal hemorrhage
occurred and, eventually, evisceration had to be per-
formed after failure of multiple treatment modalities.
Case Report
An 86-year-old man with hypertension had a history
of transient ischemic attack and deep vein thrombosis.
His blood pressure (around 134/74 mmHg) was well
controlled with bisoprolol fumarate 5 mg/day. A car-
diac pacemaker had been implanted 4 years previously
because of bradytachycardia syndrome, a kind of sick
sinus syndrome. To reduce blood clot formation and
embolic stroke risks, he was placed on anticoagulation
therapy of aspirin 100 mg twice a week and warfarin
2.5mg/day for several years. His ocular history included
chronic angle-closure glaucoma with bilateral laser iri-
dotomies. After cataract operation in both eyes 6 years
previously, intraocular pressure (IOP) was <15 mmHg
in both eyes without any antiglaucoma medication.
However, visual acuity was only hand movement in the
right eye due to ARMD with choroidal neovascular-
ization (CNV). The fundus had drusen at the macula
without CNV in the left eye, and best-corrected visual
acuity was 20/25 in the left eye.
At this presentation, the patient experienced pain-
less loss of vision in the right eye. The visual acuity
was no light perception in the right eye. IOP was nor-
mal, and the anterior chamber was deep. Slit lamp
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and funduscopic examination showed kissing retina
with subretinal hemorrhage at the macula (Figure 1).
His blood pressure was 132/72mmHg. Two days later,
he presented to the emergency department with the
chief complaint of severe headache and right ocular
pain. IOP had elevated to 45 mmHg in the right eye.
The anterior chamber was shallow and the fundus could
not be seen because of dense vitreous hemorrhage.
After administration of antiglaucoma drugs, including
rescula, alphagan, trusopt, mannitol, isobide and dia-
mox, IOP declined to 35 mmHg in the right eye, but
soon increased to 50 mmHg. The pain was much exa-
cerbated; the patient described the pain as like a bomb
exploding in his eye, causing an intolerable shearing
force.
On examination, the anterior chamber was almost
flat. Iris bombe on the temporal side implied that a
mass was pushing the lens-iris diaphragm forward.
The mass comprised vitreous hemorrhage and blood
clot behind the posterior chamber intraocular lens. 
B-scan confirmed the characteristics of massive supra-
choroidal hemorrhage with breakthrough vitreous
hemorrhage (Figure 2). Laboratory evaluation revealed
a prothrombin time of 22.0 seconds (control, 10.6
seconds) with an international normalized ratio (INR)
of 2.3, which was within the therapeutic range. It was
noteworthy that his blood pressure remained stable
throughout the clinical course.
After consulting with the cardiologist and hema-
tologist, the anticoagulation agents were withheld.
Nine days after the onset of suprachoroidal hemor-
rhage, external sclerotomy was performed and a large
amount of red-black liquefied blood was drained.
Following the procedure, the anterior chamber was
deep, IOP dropped to 35 mmHg, and his symptoms
were relieved (Figure 3). However, after just 1 day,
the pain recurred and IOP was elevated to 53 mmHg
in the right eye. The anterior chamber was flat again,
revealing a recurrent suprachoroidal hemorrhage. After
understanding the limited effect of every possible treat-
ment modality, the patient underwent evisceration to
remove the non-functional and painful eye.
Discussion
Spontaneous suprachoroidal hemorrhage is an extre-
mely rare event that has previously been described only
in isolated case reports.1–6 Risk factors include hyper-
tension, systemic anticoagulation, advanced age and
ARMD. Visual prognosis is usually poor. Yang et al6
presented 5 eyes with spontaneous suprachoroidal 
hemorrhage. Four of them had vision of no light
perception at the final follow-up even after surgical
drainage to relieve high IOP and pain. Our patient had
all the risk factors predisposing him to spontaneous
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Figure 1. Slit lamp examination shows kissing retina (arrow). Figure 2. B-scan reveals suprachoroidal hemorrhage (arrow) and
vitreous hemorrhage.
Figure 3. After suprachoroidal drainage, the anterior chamber
was deep.
suprachoroidal hemorrhage. We tried every possible
management option in vain, and the eye had to be
eviscerated. This is disappointing for ophthalmologists
but reflects the devastating prognosis of spontaneous
suprachoroidal hemorrhage.
In our patient, subretinal hemorrhage preceded the
massive suprachoroidal hemorrhage, implying the role
of CNV in initiating the process. We hypothesized that
at first, bleeding from CNV extended into the subreti-
nal space, leading to subretinal hemorrhage. Increased
vascular fragility related to advanced age and hyper-
tension, combined with anticoagulants, further precipi-
tated spontaneous suprachoroidal hemorrhage. Blood
accumulated in these potential spaces and caused ante-
rior displacement of the retina and choroids, which sub-
sequently stretched the posterior ciliary artery. Then,
appositional suprachoroidal hemorrhage occurred as a
direct result of rupturing of the blood vessels by shear
forces as the vessels entered the suprachoroidal space.
Suprachoroidal hemorrhage may present as acute
angle-closure glaucoma because of forward displace-
ment of the lens-iris diaphragm, therefore inducing
IOP elevation that cannot be relieved by patent peri-
pheral iridotomy or medical treatment. Surgical drainage
is indicated for lens-cornea touch, progressive IOP
elevation and intolerable pain. Previous literature rec-
ommended that drainage procedures be deferred for
7–14 days following suprachoroidal hemorrhage, when
clot lysis has been completed.7,8 In our patient, external
sclerotomy was performed on the 9th day, with lique-
fied blood drained out smoothly. However, rebleeding
occurred 1 day later. Recurrent suprachoroidal hem-
orrhage is uncommon after successful drainage. In this
case, the recurrence may have been due to the abnor-
mal vessels and suppressed clotting function. ARMD
resulted in CNV, which bled easily and clotted with
difficulty. Anticoagulants resulted in a non-selective
lytic state, which may have caused persistent bleeding.
A combination of these factors was likely to increase the
chances of recurrent bleeding and worsen the prognosis.
Compared to previously reported cases, our patient
was unique because his INR of prothrombin time was
within the therapeutic range (a reference value of
2.5–3.0 is considered therapeutic). Therefore, the
dosage of anticoagulation agents must be made on a
case-by-case basis, considering the attendant risks and
benefits. Following consultation with the cardiolo-
gist, the warfarin level was adjusted to maintain INR
below 1.5. The patient was informed of the risk of
bleeding in the other eye, which also had ARMD.
Regular funduscopic examination and INR evaluation
were performed. On the other hand, ARMD patients
might require more aggressive treatment for CNV to
avoid the catastrophic consequences of spontaneous
suprachoroidal hemorrhage if they are on anticoagu-
lants. However, further studies are needed to clarify
this issue.
In conclusion, this case emphasizes the risk of
spontaneous suprachoroidal hemorrhage in ARMD
patients who are on anticoagulation therapy. Therefore,
the internist must understand the potential risks and
prescribe anticoagulants meticulously. These patients
must be informed of the importance of regular follow-
up. In addition, ophthalmologists should be aware of
the hemorrhagic complications and provide prompt
diagnosis.
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